AngelMD

AngelMD is a healthcare-specific syndicate and investor network that aggregated physician and accredited-investor capital into early-stage healthcare deals. Honest read: the directory entry has minimal data, and AngelMD’s level of public activity has been variable in recent years; founders should verify current operational status and active deal flow before relying on this as a fundraising channel. The historical model was a syndicate that surfaced early-stage medical device, diagnostics, and clinical-software deals to a network of physician investors, with check sizes typically aggregated in the $250k-$2M range per deal. Best fit: medical device, diagnostics, and clinical-software founders looking for physician-investor capital and early clinical-network validation; founders comfortable with a syndicate structure rather than a single lead. Entry path is the AngelMD website directly, or LinkedIn outreach to current leadership. Not a fit for consumer wellness, biotech, or non-clinical software plays. Treat this as a complementary syndicate channel rather than a primary lead; founders should also explore Bessemer, GreatPoint Ventures, and other dedicated medtech firms as more traditional alternatives. Verify active status before committing pitch cycles.